Recent Headlines
ElectroCore’s Non-Invasive Vagus Nerve Stimulation (nVNS) Demonstrates Efficacy in Preventing Cluster Headache and Menstrual Migraine
The results of two studies, presented at the American Headache Society (AHS) Science Meeting last weekend in San Diego, show that using electroCore’s non-invasive vagus nerve stimulation (nVNS) therapy, gammaCore®, is effective at preventing both cluster headache and menstrual migraine. - June 17, 2016 - electroCore
AdvantaPure(R) Offers a New White Paper Focusing on Molded Tubing Connections; Illustrates the Risks and Expenses of Fluid Leaks in Biopharma Manufacturing Operations
Immediately available from high purity tubing manufacturer AdvantaPure is a report titled “How Molded Manifold Assemblies Prevent Leaks and Costly Consequences.” It addresses the risks and costs associated with tubing-to-fitting connection leaks and presents a solution, namely the use of molded connections. The white paper shows how critical leak risk becomes based on the number of connections in a manifold assembly. Additional white papers are available as well. - June 16, 2016 - AdvantaPure
ValueTrak 8.0 Release Re-Imagines Fee-for-Service Scorecarding with New Data Quality Metrics and Robust Customization Capabilities
ValueCentric, the industry leader in healthcare channel intelligence, announced enhancements to their Scorecard capabilities as part of ValueTrak 8.0 software release. Improvements include advanced Specialty and Channel Data Management metrics, integrating data completeness, timeliness, and... - June 15, 2016 - ValueCentric
South Korea Patent Allowance for Anti-Obesity Pet Vaccines to Braasch Biotech LLC
Braasch Biotech granted Anti-Obesity patent for pets by Korean Intellectual Property Office. Commercial utility and novelty for first therapeutic vaccine for use in obese dogs, cats and horses. - June 11, 2016 - Braasch Biotech LLC
Seven Presentations on electroCore’s Treatment for Cluster Headache and Migraine Will Feature at American Headache Society Science Meeting
Recent clinical and preclinical results using electroCore’s non-invasive vagus nerve stimulation (nVNS, gammaCore®) therapy in the treatment and prevention of primary headache are the subject of seven presentations at the American Headache Society (AHS) Science Meeting being held at San... - June 08, 2016 - electroCore
ALPCO Releases New Broad Range Periostin ELISA
ALPCO now has a new broad range Periostin ELISA capable of measuring elevated levels of periostin consistent with current research. - June 07, 2016 - ALPCO
June 30, 2016 Webinar: Behavioral Health Patient Engagement: Using Motivational Interviewing to Improve Outcomes
The latest applications of motivational interviewing to engage individuals with behavioral health issues will be explored during a June 30, 2016 webinar on Behavioral Health Patient Engagement sponsored by the Healthcare Intelligence Network. - June 06, 2016 - Healthcare Intelligence Network
Tabula Rasa HealthCare CEO Calvin H. Knowlton Named Technology CEO of the Year
Tabula Rasa HealthCare Chairman and CEO, Calvin H. Knowlton, received the 2016 PACT Enterprise Award for Technology CEO of the Year at a gala event in Philadelphia, May 12. While accepting the award, Knowlton stated, "TRHC results include enhanced medication-related outcomes and greater operational efficiency. The work we are doing in medication informatics, personalized medication management, and compliance/assurance is exciting and, we believe, game changing." - June 03, 2016 - Tabula Rasa HealthCare
Head and Neck Squamous Cell Carcinoma - Pipeline Insights, 2016
DelveInsight, the leading market research and consulting company has added a new report, "Head and Neck Squamous Cell Carcinoma - Pipeline Insights, 2016" to its portfolio. With this launch DelveInsight now has 700+ Reports on Indication Pipeline Insight. - June 02, 2016 - DelveInsight
Theater Slim PCR Cycler - Small Footprint, Small Price, Great Flexibility
MoBiTec is selling an incredibly small, light, and slim (4 cm), yet fully functional PCR instrument - The Theater Slim PCR Cycler. It is beneficial to small-sized labs and in-the-field research. - June 01, 2016 - MoBiTec GmbH
Makers Nutrition Receives Nine Stevie® Awards in 2016 American Business Awards
Makers Nutrition and other Stevie winners will be presented with their awards on June 20th in New York. - May 26, 2016 - Makers Nutrition, LLC
Pancreatic Cancer - Pipeline Insights, 2016
DelveInsight, the leading market research and consulting company has added new report Pancreatic Cancer - Pipeline Insights, 2016 to its portfolio. With this launch Delveinsight now has 700+ Reports on Indication Pipeline Insight. - May 26, 2016 - DelveInsight
MoBiTec GmbH Teams Up with TargetMol, US, to Offer Thousands of Inhibitors and Predetermined Screening Libraries
TargetMol supplies over 3000 compounds used in the study of cell signaling pathways and drug discovery. TargetMol provides more than 32 types of compound libraries, available for cell induction, signaling pathway, and high-throughput screening (HTS). - May 25, 2016 - MoBiTec GmbH
BÜHLMANN Laboratories AG Announces New Health Canada License for the BÜHLMANN fCAL® turbo Assay
BÜHLMANN Laboratories AG's immunoturbidimetric assay for fecal calprotectin quantification, BÜHLMANN fCAL® turbo is now commercially available in Canada and is Health Canada licensed. - May 24, 2016 - BUHLMANN Diagnostics Corp
In 2016 Population Health Metrics, Risk-Based Payment Models Shift Scrutiny to "Rising Risk"
New population health management metrics from the Healthcare Intelligence Network (HIN) indicate that healthcare organizations are doubling down on the "rising risk" - individuals with two or more unmanaged health conditions - to maximize value-based reimbursement. - May 24, 2016 - Healthcare Intelligence Network
ValueCentric’s Training Conference, Focus 2016, Sells-Out in Record Time
ValueCentric, the leader in healthcare channel intelligence, today announced their annual user-training conference, being held in Princeton, NJ May 24th and 25th, has sold out. Anticipation for this event has accelerated with the company’s expanded data service offerings, a significant... - May 20, 2016 - ValueCentric
Now Available: A Red-Fluorescent cADDis Assay Kit, Manufactured by Montana Molecular, for Measuring cAMP Changes in Live Mammalian Cells
Cyclic AMP (cAMP) is the prototypical second messenger. The major receptor in eukaryotic cells, cAMP-dependent Protein Kinase (PKA), is ubiquitous. cAMP affects many different physiological and biochemical processes, including the activity of kinases. In contrast to the hitherto available green-fluorescent cADDis kit, the red-fluorescent counterpart can be used in combination with green-fluorescent gene constructs, such as GFP, or ion indicators. - May 19, 2016 - MoBiTec GmbH
electroCore's GammaCore is Both Effective and Cost Effective for the Treatment of Cluster Headache
A paper in the Journal of Headache and Pain reports that non-invasive stimulation of the vagus nerve (nVNS) is a cost effective therapy for cluster headache. These findings were based on reductions in medication use and improvements in quality of life. The publication also notes that further... - May 18, 2016 - electroCore
DelveInsight's Latest Release: Acute Ischemic Stroke - Pipeline Insights, 2016
DelveInsight, the leading market research and consulting company has added a new report Acute Ischemic Stroke - Pipeline Insights, 2016 to its portfolio. With this launch Delveinsight now has 700+ Reports on Indication Pipeline Insight. - May 17, 2016 - DelveInsight
Lysosomal Storage Disorder - Pipeline Insights, 2016
DelveInsight, the leading market research and consulting company has added new report Lysosomal Storage Disorder - Pipeline Insights, 2016 to its portfolio. With this launch Delveinsight now has 700+ Reports on Indication Pipeline Insight. - May 14, 2016 - DelveInsight
Antibody Drug Conjugate Insight: Technology Trend, Pipeline Assessment and Competitive Landscape, 2016
DelveInsight has added a new report “Antibody Drug Conjugate Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape, 2016” to its Portfolio. - May 14, 2016 - DelveInsight
Anticoagulants-Market Insights & Drugs Sales Forecast (VTE & AF)-2020 - A DelveInsight Report
According to DelveInsight researchers, the Anticoagulants (VTE & AF) Therapeutics Market was around $11.4 billion in 2015 and is estimated to reach $17.2 billion by 2020 growing at a CAGR of 8.59% from 2015 to 2020. - May 12, 2016 - DelveInsight
Obsessive Compulsive Disorder (OCD) - Pipeline Insights, 2016
DelveInsight, the leading market research and consulting company has added new report Obsessive Compulsive Disorder (OCD) - Pipeline Insights, 2016 to its portfolio. With this launch Delveinsight now has 700+ Reports on Indication Pipeline Insight. In addition to this our research expertise provides our clients with up to date information of market till date order has been placed. - May 11, 2016 - DelveInsight
Careington Attends Transatlantic Business Conference
Careington International Corporation CEO Barbara Williams will be attending the British American Business Council (BABC) annual Transatlantic Business Conference in London on May 11 and 12, 2016. Attending with Williams will be Bruce Bernstein, Assistant Vice President of Global Sales Development with Careington’s UK affiliate Munroe Sutton, and Head of Munroe Sutton’s Business Development division, Robert Malvasi. - May 11, 2016 - Careington
Makers Nutrition Launches Stock Softgels Brand
Nutraceutical Company Powers Softgel Products to Vitamin and Supplement Businesses - May 10, 2016 - Makers Nutrition, LLC
3097 Pounds Shed by Minnesotans in the Slim Down Challenge; Winners Announced
The Slim Down Challenge, hosted by Seattle Sutton’s Healthy Eating (SSHE) of Minnesota, was a 16-week challenge for participants to improve their health and lose weight through their nutrition. Over 300 Minnesotans entered the Challenge, with 81 of them completing the full 16-week period, losing a total of 3097 pounds, and achieving substantial improvements in their health metrics as a result. - May 05, 2016 - Seattle Sutton's Healthy Eating
The Morgan Leary Vaughan Fund Honors Dr. Edmund F. La Gamma
The Morgan Leary Vaughan Fund honored Edmund F. La Gamma, MD, Chief, Newborn Medicine at Maria Fareri Children's Hospital, a Member of the Westchester Medical Center Health Network, with the inaugural Lily Pedro Award for Excellence. The event, The 1st Annual Morgan's FunDay, was held at the... - May 05, 2016 - The Morgan Leary Vaughan Fund, Inc.
RuCor Strategies LLC Announces the Launch of CamCare, the First National Membership Benefit Reimbursement Program for Complementary Alternative Medicine Services
Designed membership plans help consumers pay for complementary alternative medicine visits. - May 04, 2016 - RucorStrategies, LLC / Camcare
NJHA Brings Medication Risk Mitigation Services to New Jersey Hospitals Through Strategic Alliance with Tabula Rasa HealthCare
New Jersey Hospital Association and Tabula Rasa HealthCare (TRHC) have entered into a 3-year agreement to offer TRHC's proprietary Medication Risk Mitigation™ products and services to NJHA’s nearly 400 member healthcare organizations. - May 02, 2016 - Tabula Rasa HealthCare
Tabula Rasa HealthCare Names Kristen Propp Creative Director; Healthcare Technology Company Expands Marketing Heft with New Hire
Tabula Rasa HealthCare, Inc. (TRHC) President Orsula V. Knowlton announced graphic designer, Kristen Propp, has joined the healthcare technology company as Creative Director. TRHC is a leader in providing patient-specific, data-driven technology and solutions for health care organizations. - May 02, 2016 - Tabula Rasa HealthCare
Sentynl Therapeutics, Inc. Acquires Abstral®
Sentynl Therapeutics, Inc. (“Sentynl”) announced that it acquired the rights to market Abstral® in the U.S. from Galena Biopharma. Abstral® is indicated for the management of breakthrough pain in cancer patients 18 years of age and older who are already receiving and who are... - May 01, 2016 - Sentynl Therapeutics, Inc.
Sentnyl Therapeutics, Inc. Re-Launches Abstral® in the United States
Sentynl Therapeutics, Inc. (“Sentynl”) announced that its commercial organization relaunched Abstral® in the United States. Sentynl acquired the rights to market Abstral® from Galena Biopharma in November 2015. Abstral® is indicated for the management of breakthrough pain... - May 01, 2016 - Sentynl Therapeutics, Inc.
Sentynl Therapeutics, Inc. Welcomes Darren Pincus as Vice President of Business Development
Sentynl Therapeutics, Inc. (“Sentynl”) announced that Darren Pincus joined Sentynl as its Vice President and head of Business Development. Mr. Pincus is a highly experienced business development professional with a strong track record of successfully completed transactions. Prior to... - May 01, 2016 - Sentynl Therapeutics, Inc.
Sentynl Therapeutics, Inc. Launches Sentynl Patient Services
Sentynl Therapeutics, Inc. (“Sentynl”) announced that it launched Sentynl Patient Services to enhance patient access to its products. Sentynl Patient Services provides support to patients who want assistance with investigating their benefits, affording their medications and locating... - May 01, 2016 - Sentynl Therapeutics, Inc.
Sentynl Therapeutics, Inc. Launches Its Commercial Organization
Sentynl Therapeutics, Inc. (“Sentynl”) announced that it launched its commercial organization including a full-time, professional sales force of key account specialists. About Sentynl Therapeutics. Sentynl provides healthcare professionals with treatment solutions that enable them to... - April 30, 2016 - Sentynl Therapeutics, Inc.
Sentynl Therapeutics, Inc. Welcomes Michael Hercz as Its Senior Vice President and General Counsel
Sentynl Therapeutics, Inc. (“Sentynl”) announced that Michael Hercz joined Sentynl as its Senior Vice President, General Counsel and Chief Compliance Officer. Mr. Hercz brings more than 18 years of legal, compliance and risk management experience to Sentynl. Prior to Sentynl, Mr. Hercz... - April 30, 2016 - Sentynl Therapeutics, Inc.
Compounding Pharmacy Supplies Medication for Study Using Edetate Disodium Therapy
Following the generally positive outcome of the National Institutes of Health-funded Trial to Assess Chelation Therapy (TACT)[1] study completed in 2012, it was decided that further research was warranted to test the safety and effectiveness of Chelation therapy as a treatment option for... - April 27, 2016 - Universal Arts Compounding Pharmacy
ALPCO’s Bioactive Leptin ELISA Allows Researchers to Differentiate Between Leptin Resistance and Non-functional Leptin
ALPCO recently announced the release of its Bioactive Leptin ELISA, offering diabetes and obesity researchers a new tool to differentiate between leptin resistance and non-functional leptin. The assay allows for the measurement of leptin in human serum through the process of binding leptin to... - April 26, 2016 - ALPCO
Bioquark Inc. and Revita Life Sciences Receive IRB Approval for First-In-Human Brain Death Study
Bioquark Inc. and Revita Life Sciences Receive IRB Approval for First-In-Human Brain Death Study - The Reanima Project - Is Death Reversible? - April 25, 2016 - Bioquark Inc.
Morgan's Fund Issues Statement on Selection for NORD's Natural History Studies Project
A statement was issued today by Stephanie M. Vaughan, Co-founder and President of The Morgan Leary Vaughan Fund (Morgan’s Fund), regarding the announcement of the National Organization for Rare Disorders’ (NORD) selection of Natural History Studies Project participants. - April 22, 2016 - The Morgan Leary Vaughan Fund, Inc.
ValueCentric’s Order Management Module Becomes Choice Solution for Top Pharma Manufacturers
ValueCentric, the industry leader in healthcare channel intelligence, announced today that their Order Management application surpassed a significant milestone of $200 billion in processed orders annually. Following two recent implementations, the company is now processing critical order data for... - April 22, 2016 - ValueCentric
Montana Molecular Appoints MoBiTec, Germany, as Distributor to Sell Genetically Encoded Fluorescent Biosensors
While fluorescent dye-based assays are powerful tools for high-throughput screening in engineered cell lines or cell lysates to show that signaling has occurred, genetically encoded sensors that measure dynamic processes in physiologically relevant cells provide a higher level of insight into how signals are regulated in both space and time. It is the regulation of signaling that controls cell function in both health and disease. - April 16, 2016 - MoBiTec GmbH
Hypoxia Inducible Factor (HIF) Inhibitors - Pipeline Insights, 2016
DelveInsight, the leading market research and consulting company has added new report Hypoxia Inducible Factor (HIF) Inhibitors - Pipeline Insights, 2016 to its portfolio. With this launch Delveinsight now has 700+ Reports on Indication Pipeline Insight. In addition to this their research expertise provides their clients with up to date information of market till date order has been placed. - April 16, 2016 - DelveInsight
The New York Center for Nanomedicine Research, Inc. is Signing a Strategic Agreement to Provide Drug Delivery Systems to ICAHRIS in Canada
Strategic agreement for the development of nanoparticules with application in Cancer, Type 2 diabetes and inflammation. The NYCNMR is providing to ICAHRIS, its innovative platform dedicated to Nanomedicine. The NY center is located in the upcoming Bio-Cluster located in Buffalo NY. - April 14, 2016 - New York Center for Nanomedicine Research, Inc.
BreviTest Awarded Grant from National Institute on Drug Abuse to Optimize Device for Rapid Cannabis Testing
BreviTest Technologies has been awarded a $234,412 grant from the National Institute on Drug Abuse of the National Institutes of Health (NIH) to explore rapid testing for THC, the main active ingredient in cannabis. The federal funds, awarded under the NIH’s Small Business Innovation Research... - April 14, 2016 - Cayman Chemical Company
Biomedical Strategy Expert Brett Giroir Joins Noninvasix Scientific Advisory Board
Medical device firm Noninvasix, Inc., developers of a patient monitoring system that accurately and noninvasively measures the amount of brain oxygenation in preterm infants, announced today that life science strategy expert Brett Giroir, M.D. has been appointed to the company’s Scientific... - April 13, 2016 - Noninvasix
Pancreatic Cancer – Market Insights, Epidemiology and Market Forecast-2020
DelveInsight is a leading Business Consultant and Market Research Firm which has become the knowledge partner for biotechnology and pharmaceutical companies by providing competitive intelligence information which aids them to strategize and discover the target areas & potential customers for... - April 13, 2016 - DelveInsight
NICE Provides Positive Guidance on electroCore’s gammaCore Treatment for the Prevention and Acute Treatment of Migraine and Cluster Headache
The UK’s National Institute of Health and Care Excellence (NICE) has published guidance that electroCore’s non-invasive vagus nerve stimulation treatment (gammaCore) for the prevention and acute treatment of migraine and cluster headache is safe and can now be used in the NHS. The... - April 09, 2016 - electroCore
FriendsSalonNSpa.ca Announces a Reduction in the Prices of Popular Botox and Juvederm Filler
Botox and fillers that are a proven way to eliminate one's facial wrinkles and fine lines in minutes are now offered at a discount online. - April 07, 2016 - Friends Salon N Spa
For Healthcare Majority, Digital Health Elevates Patient Experience, Curbs Readmissions
For most digital health adopters, the technologies use heightens patient satisfaction and reduces hospital readmissions, according to 2016 market data from the Healthcare Intelligence Network (HIN). - April 07, 2016 - Healthcare Intelligence Network